ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough cancers
Disease control CompletedThis early-phase study tested a new drug called MK-4464, given alone or with another drug (pembrolizumab), in 64 people with advanced solid tumors that had not responded to standard treatments. The main goals were to check safety and how the drug moves through the body. This is n…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a new drug called ADG116, alone or combined with other immune-boosting drugs, in 72 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The study is now co…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Adagene Inc • Aim: Disease control
Last updated May 14, 2026 12:04 UTC